Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners.
Andrew pitches Integrated Research (ASX:IRI), Claude makes the case for Xref (ASX:XF1), and we answer some questions from listeners.
With a little over a week before the end of the year, I think our little investment community can safely declare success for 2024. The Strawman Index, which tracks the most widely held stocks across member portfolios, smashed it out of the park with a 23.5% return for the 12 months through to December 19. Handily outpacing what was a very […]
The Australian share market has lost close to 30% in just three weeks. That’s something we’ve seen only a handful of times in all of history. It’s far from an irrational move either, when you consider just how quickly the coronavirus pandemic has escalated. Consider this: Entire countries have gone into lock down Infections are continuing to grow at an exponential rate […]
Modern economics is littered with ideas that are, frankly, wrong. Not obviously so, which is partly why they are so hard to kill. That, and the fact they tend to be politically comforting, at least in terms of their intended outcomes. That those outcomes would indeed be nice if achieved, and often come from the best of intentions, is not […]